Fetal Fentanyl Syndrome: Unveiling a New Syndrome Linked to Fentanyl Use During Pregnancy
Dr. Karen Gripp, MD, Chief of the Division of Medical Genetics at Nemours Children’s Health in Wilmington, has been at…
January 8, 2019
The article explores FDNA’s cutting-edge AI technology, which identifies genetic conditions by analyzing facial characteristics. Using the Face2Gene platform, FDNA’s AI scans photos to detect subtle phenotypic markers linked to various genetic disorders. This innovative approach leverages a vast database and deep learning algorithms to provide rapid and accurate diagnoses that traditional methods might miss. By recognizing specific facial characteristics, the technology facilitates early detection and tailored treatments for patients. The article highlights the transformative potential of FDNA’s AI in revolutionizing medical diagnostics, particularly for rare and complex genetic conditions, thereby improving patient care and outcomes.
Dr. Karen Gripp, MD, Chief of the Division of Medical Genetics at Nemours Children’s Health in Wilmington, has been at…
Dr Giulia Pascolini, an esteemed Italian M.D. and Ph.D., is currently responsible for the Genetic Counselling Service of the Istituto…
Founded in 2017, the Spanish Coffin Siris Syndrome Association is an organization dedicated to supporting families affected by this rare…